MRSA-UV's Ten Most Unwanted Superbugs has been conceived in order to permit both professional healthcare workers and the general public a more practical way to visualize the most common and virulent microbes plaguing our environment today.
These hypervirulent microbes attack so quickly and cause such devastating damage to the human body that it is to everyone's advantage to get to know about these guys before they get to know you. Due to their overwhelming resistance to antibiotics and fast multiplication they will require you to make rapid and decisive decisions before they take hold.
Antibiotic resistance isn't the only worrisome thing about NAP1. C. diff normally makes two toxins. The NAP1 strain makes 16 times more toxin A and 23 times more toxin B. And it also makes another toxin, called binary toxin, although it's not yet clear how this toxin affects humans.
To date, the NAP1 strain has been reported in 37 U.S. states and in the District of Columbia.
A recent report shows that adult C. diff hospitalizations doubled between 2000 and 2005 to about 300,000 hospitalizations a year. That's more hospitalizations than are seen with MRSA, which sends about 126,000 Americans to the hospital each year.
The CDC's C. diff expert, L. Clifford McDonald, MD, tells WebMD that if you count pediatric C. diff cases and cases in the community that do not enter the hospital, there are probably half a million U.S. cases of C. diff infection each year.